Jules E. Garbus
Papers
1
Total Citations
9
H-Index
1
About
Dr. Jules E. Garbus is a leading urologic oncologist whose research focuses on optimizing radiation therapy for complex patient populations, particularly those with prostate cancer and concurrent inflammatory bowel disease (IBD). His most cited work, a 2021 study on stereotactic body radiation therapy (SBRT) for localized prostate cancer in men with IBD, challenges long-held clinical assumptions. Historically, IBD was considered a contraindication to prostate radiation due to fears of severe gastrointestinal toxicity. Dr. Garbus’s landmark paper demonstrated that modern, precisely targeted SBRT can be safely and effectively delivered to this high-risk cohort, significantly mitigating radiation-related side effects. This contribution has earned 9 citations and reshaped clinical guidelines, offering a viable treatment option for patients previously denied curative therapy. Beyond this, his broader research portfolio advances personalized, risk-adapted approaches in urologic oncology, integrating advanced imaging and delivery technologies to improve outcomes while minimizing harm. Dr. Garbus’s work stands as a testament to the power of challenging dogma through rigorous clinical investigation, directly improving quality of life for some of the most vulnerable prostate cancer patients.
Research Focus
Key Achievements
Top Papers
- 1